The U.S. Food and Drug Administration (FDA) today issued final recommendations to increase the supply of safe and effective influenza vaccines for both seasonal and pandemic use.
Marc Hiller, associate professor of health management and policy at the University of New Hampshire and a specialist in ethical issues in public health, is available to comment on the recent federal order that placed a Georgia man with a lethal form of tuberculosis into quarantine.
Veterinarians who work with birds are at increased risk for infection with avian influenza virus and should be among those with priority access to pandemic influenza vaccines and antivirals, according to a study conducted by researchers in the University of Iowa College of Public Health.
Adults who have recovered from the potentially deadly H5N1 strain of avian influenza may hold the key to future treatments for the virus, according to an international team of researchers.
Using antibodies derived from immune cells from recent human survivors of H5N1 avian influenza to successfully treat H5N1-infected mice as well as protect them from an otherwise lethal dose of the virus, revealed by researchers.
The Health Protection Agency is providing expert support and advice to the National Public Health Service for Wales after an H7N2 avian influenza infection was found in birds on a small farm in north Wales. The Agency has carried out tests on specimens from nine people associated with the incident; seven are from Wales and two were from north west England.
Cases of the H7 flu virus have been identified following the discovery of avian flu at a smallholding near Corwen in North Wales, UK. 12 avian flu contacts had been identified who have or have had symptoms of a flu like illness or conjunctivitis. No one is seriously ill.
Starting with blood of patients who survived a bout of avian flu (infection with the H5N1 strain), Cameron Simmons (of the Oxford University Clinical Research Unit at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam) and colleagues generated neutralizing human monoclonal antibodies and show that they can halt viral growth in mice deliberately infected with H5N1 virus.
An international team of scientists, including researchers from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, report using antibodies derived from immune cells from recent human survivors of H5N1 avian influenza to successfully treat H5N1-infected mice as well as protect them from an otherwise lethal dose of the virus.
The World Health Assembly (WHA), the supreme decision-making body of the World Health Organization (WHO), wrapped-up its sixtieth session, reaching last-minute agreement on two key resolutions on Pandemic influenza preparedness and Public health, innovation and intellectual property.